William Blair Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$198M Sell
351,621
-89,703
-20% -$57.5M 0.65% 28
2025
Q4
$299M Sell
441,324
-17,695
-4% -$12.1M 0.83% 16
2025
Q3
$293M Sell
459,019
-226,069
-33% -$137M 0.76% 23
2025
Q2
$367M Buy
685,088
+47,977
+8% +$22.9M 0.98% 15
2025
Q1
$268M Buy
637,111
+214,978
+51% +$93.3M 0.75% 27
2024
Q4
$175M Buy
422,133
+369,471
+702% +$162M 0.43% 72
2024
Q3
$26.6M Sell
52,662
-14,459
-22% -$7.02M 0.07% 266
2024
Q2
$32.7M Sell
67,121
-1,907
-3% -$957K 0.09% 203
2024
Q1
$37.3M Buy
69,028
+699
+1% +$382K 0.1% 195
2023
Q4
$37.9M Buy
68,329
+1,194
+2% +$561K 0.11% 179
2023
Q3
$29.4M Sell
67,135
-7,906
-11% -$3.94M 0.1% 222
2023
Q2
$37.7M Sell
75,041
-279
-0.4% -$134K 0.12% 174
2023
Q1
$37.7M Sell
75,320
-2,379
-3% -$1.14M 0.13% 159
2022
Q4
$31.7M Sell
77,699
-29,947
-28% -$11.6M 0.12% 185
2022
Q3
$35.1M Sell
107,646
-2,956
-3% -$1.09M 0.14% 155
2022
Q2
$38.8M Sell
110,602
-5,827
-5% -$2.38M 0.14% 159
2022
Q1
$63.7M Sell
116,429
-7,559
-6% -$3.98M 0.19% 137
2021
Q4
$81.6M Buy
123,988
+2,201
+2% +$1.38M 0.22% 119
2021
Q3
$75.7M Sell
121,787
-1,395
-1% -$937K 0.21% 123
2021
Q2
$77.8M Buy
123,182
+27,944
+29% +$15.4M 0.24% 122
2021
Q1
$46.6M Sell
95,238
-14,203
-13% -$7.12M 0.15% 150
2020
Q4
$54.7M Sell
109,441
-19,543
-15% -$8.74M 0.18% 126
2020
Q3
$50.7M Sell
128,984
-15,201
-11% -$5.62M 0.2% 124
2020
Q2
$47.6M Sell
144,185
-22,715
-14% -$6.58M 0.19% 128
2020
Q1
$40.4M Buy
166,900
+51,778
+45% +$13.5M 0.2% 127
2019
Q4
$30.1M Sell
115,122
-42,745
-27% -$11.3M 0.12% 155
2019
Q3
$42.9M Sell
157,867
-25,544
-14% -$7.11M 0.18% 127
2019
Q2
$50.5M Buy
183,411
+61,078
+50% +$15M 0.21% 120
2019
Q1
$27.4M Buy
122,333
+69,588
+132% +$14.4M 0.12% 160
2018
Q4
$9.81M Sell
52,745
-97,236
-65% -$19.9M 0.05% 312
2018
Q3
$37.4M Buy
149,981
+475
+0.3% +$115K 0.13% 176
2018
Q2
$32.6M Sell
149,506
-122,779
-45% -$25.3M 0.12% 180
2018
Q1
$52.1M Sell
272,285
-456,440
-63% -$84.2M 0.2% 142
2017
Q4
$114M Buy
728,725
+500,359
+219% +$78.8M 0.44% 79
2017
Q3
$35.5M Sell
228,366
-215,105
-49% -$34M 0.13% 171
2017
Q2
$71.6M Sell
443,471
-82,629
-16% -$13.4M 0.26% 115
2017
Q1
$81.3M Sell
526,100
-191,939
-27% -$26.5M 0.31% 104
2016
Q4
$84.2M Sell
718,039
-993,908
-58% -$113M 0.34% 100
2016
Q3
$193M Sell
1,711,947
-221,047
-11% -$23.3M 0.73% 42
2016
Q2
$179M Sell
1,932,994
-627,528
-25% -$53.9M 0.71% 44
2016
Q1
$201M Buy
2,560,522
+109,665
+4% +$7.9M 0.79% 40
2015
Q4
$179M Buy
2,450,857
+218,502
+10% +$15.6M 0.72% 41
2015
Q3
$166M Buy
+2,232,355
New +$160M 0.34% 87

Other funds holding IDXX

William Blair Investment Management's IDXX Position: Q1 2026 in Review

William Blair Investment Management reduced its Idexx Laboratories (IDXX) stake by 20% in Q1 2026, selling an estimated $57.5M and leaving 351,621 shares worth $198M. The position accounts for 0.65% of the portfolio, ranked #28.

William Blair Investment Management first reported a position in IDXX in Q3 2015 and has held it in 43 quarters since. The position peaked at $367M in Q2 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • William Blair Investment Management held 351,621 shares of Idexx Laboratories worth $198M as of Q1 2026.
  • William Blair Investment Management sold 89,703 Idexx Laboratories shares in Q1 2026, an estimated $57.5M.
  • Idexx Laboratories made up 0.65% of William Blair Investment Management's portfolio in Q1 2026, its #28 holding.
  • William Blair Investment Management first reported a position in Idexx Laboratories in Q3 2015 and has held it in 43 quarters since.
  • William Blair Investment Management's Idexx Laboratories position peaked at $367M in Q2 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on William Blair Investment Management's 13F filing for Q1 2026, filed 8 May 2026.